Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hotspot Mutations Optimize the Oncogenic-Immunogenic Trade-off.

Cancer discovery - 6 Jul 2022

Abstract excerpt

The fitness of TP53 mutations can be modeled by mutational signatures, oncogenic activity, and immunogenicity.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinogenesis
Share to Mutation
Share to Oncogenes
Share to Tumor Suppressor Protein p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35593588
DOI: 10.1158/2159-8290.CD-RW2022-090

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hotspot Mutations Optimize the Oncogenic-Immunogenic Trade-off.PMID 35593588Read ↗

Fundamental immune-oncogenicity trade-offs define driver mutation fitness.Semantic proximity Read ↗

Low immunogenicity of common cancer hot spot mutations resulting in false immunogenic selection signals.Semantic proximity Read ↗

Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.Semantic proximity Read ↗

A census of predicted mutational epitopes suitable for immunologic cancer control.Semantic proximity Read ↗

Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network.Semantic proximity Read ↗

A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.Semantic proximity Read ↗

Immunogenicity and Immune Silence in Human Cancer.Semantic proximity Read ↗

Tumor Mutational Burden Shapes Success and Resistance in Cancer Immunotherapy.Semantic proximity Read ↗

Tumor mutational burden shapes success and resistance in cancer immunotherapySemantic proximity Read ↗

Characterizing MHC-I Genotype Predictive Power for Oncogenic Mutation Probability in Cancer Patients.Semantic proximity Read ↗

Convergent TP53 loss and evolvability in cancer.Semantic proximity Read ↗

Mutation hotspots in the p53 gene in tumors of different origin: correlation with evolutionary conservation and signs of positive selection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.